The Small Molecule Ephrin Receptor Inhibitor, GLPG1790, Reduces Renewal Capabilities of Cancer Stem Cells, Showing Anti-Tumour Efficacy on Preclinical Glioblastoma Models.
Gravina GL, Mancini A, Colapietro A, Delle Monache S, Sferra R, Vitale F, Cristiano L, Martellucci S, Marampon F, Mattei V, Beirinckx F, Pujuguet P, Saniere L, Lorenzon G, van der Aar E, Festuccia C.
Gravina GL, et al. Among authors: vitale f.
Cancers (Basel). 2019 Mar 13;11(3):359. doi: 10.3390/cancers11030359.
Cancers (Basel). 2019.
PMID: 30871240
Free PMC article.